Chalcone derivatives with activity against drug-resistant bacteria
A technology of chalcone derivatives and drug-resistant bacteria, applied in antibacterial drugs, organic chemistry and other directions, can solve problems such as severe antibiotic treatment situation, and achieve good bacteriostatic effect and good bacteriostatic effect.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0035] Preparation of compound 5a
[0036] Take sodium hydroxide (370mg, 9.25mmol) in a 250ml single-necked round bottom flask, add 50ml of water and dissolve under magnetic stirring at room temperature; then compound 1 (p-aminoacetophenone) (1.00g, 7.40mmol) and compound 2 (2 -Pyridinecarbaldehyde) (722ul, 7.58mmol) was added in a 100ml Erlenmeyer flask, 50ml of ethanol was added to ultrasonically until the system was basically clear, and then the clear solution was added dropwise (1d / s) to the above-mentioned stirred sodium hydroxide solution In the single-necked bottle, after the dropwise addition, the reaction was continued at room temperature, and the system was brownish yellow and clear. After about 6h, TLC detection (PE:EA=1:1) showed that the reaction was complete. The reaction was stopped, and the reaction system was poured into about 50ml of ice water, and a large amount of yellow solids were precipitated immediately, filtered with suction, washed with water until n...
Embodiment 2
[0043] Preparation of compound 5b
[0044] Compound 1 is p-aminoacetophenone, compound 2 is 3-fluoro-2-pyridinecarbaldehyde, and compound 4 is chloroacetyl chloride. The preparation method is the same as in Example 1.
[0045] The product is a pale yellow solid with a yield of 98.8%, m.p.: 157-158°C.
[0046] 1 H NMR (400MHz, CDCl3) δ8.43 (d, J = 4.4Hz, 1H), 8.39 (s, 1H), 8.10 (dd, J = 24.8, 12.0Hz, 3H), 7.98 (dd, J = 15.3, 1.1Hz, 1H), 7.66(d, J=8.7Hz, 2H), 7.48–7.33(m, 1H), 7.28(dt, J=8.5, 4.3Hz, 1H), 4.16(s, 2H).
[0047] 13 C NMR(101MHz,CDCl3)δ187.55,163.02,144.75,144.70,140.02,133.67,133.28,129.25,125.45,125.41,124.95,124.90,123.00,122.81,118.36,76.33,76.21,76.01,75.69,41.87,-0.00, -1.03.
[0048] HR-MS (ESI) Calcd for C 16 h 13 ClFN 2 o 2 [M+H]+:319.0650,found:319.0648.
Embodiment 3
[0050] Preparation of compound 5c
[0051] Compound 1 is p-aminoacetophenone, compound 2 is 5-bromo-2-pyridinecarbaldehyde, and compound 4 is chloroacetyl chloride. The preparation method is the same as in Example 1.
[0052] The product is a pale yellow solid with a yield of 85.3%, m.p.: 226-227°C.
[0053] 1 H NMR (400MHz, DMSO) δ10.72(s, 1H), 8.81(d, J=1.9Hz, 1H), 8.23–8.08(m, 4H), 7.91(d, J=8.4Hz, 1H), 7.80 (d, J=8.6Hz, 2H), 7.69(d, J=15.4Hz, 1H), 4.32(d, J=6.3Hz, 2H).
[0054] 13 C NMR(101MHz,DMSO)δ187.63,165.24,151.71,150.73,143.11,141.26,139.75,132.41,130.02,126.29,125.69,121.21,118.86,43.60,40.13,39.92,39.71,39.51,39.30,39.09,38.88.
[0055] HR-MS (ESI) Calcd for C 16 h 13 BrClN 2 o 2 [M+H] + :378.9849,found:378.9850.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


